The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation

Transplantation

Volumn 67, Issue 3, 1999, Pages 385-391

  Fredrich, Ragini ^a   Toyoda, Mieko ^a,b   Czer, Lawrence S C ^a   Galfayan, Karine ^a   Galera, Odette ^a   Trento, Alfredo ^a   Freimark, Dov ^a   Young, Scott ^a   Jordan, Stanley C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGRAFT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL INFILTRATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT SURVIVAL; HEART GRAFT; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0033557370     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199902150-00008     Document Type: Article

References (36)

1. Lones MA, Czer LS, Trento A, Harsty D, Miller JM, Fishbein MC. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. J Heart Lung Transplant 1995; 14(1 Pt 1): 151.
2. Rabin BS, Griffith BP, Hardesty RL. Vascular endothelial cell HLA-DR antigen and myocyte necrosis in human allograft rejection. J Heart Transplant 1985; 4: 293.
3. Cerilli J, Brasile L, Galouzis T, Lempert N, Clarke J. The vascular endothelial cell antigen system. Transplantation 1985; 39: 286.
4. Brasile L, Zerbe T, Rabin B, et al. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Transplantation 1985; 40: 672.
5. Trento A, Hardesty RL, Griffith BP, et al. Role of antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation. J Thorac Cardiovas Surg 1988; 95: 37.
6. Hart DNJ, Fuggle SV, Williams KA, et al. Localization of HLA-ABC and DR antigens in human kidney. Transplantation 1981; 31: 428.
7. Wagner CR, Vetto RM, Burger DR. Expression of I-region-associated antigen (Ia) and interleukin-1 by subcultured human endothelial cells. Cell Immunol 1985; 93: 91.
8. Collins T, Korman AJ, Wake CT, et al. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain genes in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 1984; 81: 4917.
9. Cerilli GJ, Brasile L. Tissue-specific antigens - a role in organ transplantation theory for the existence of tissue-specific antigens. In: Cerilli GJ, ed. Organ transplantation and replacement. Philadelphia: Lippincott, 1988: 208.
10. Schook LB, Wood N, Mohanakumar T. Identification of human vascular endothelial cell/monocyte antigenic system using monoclonal antibodies. Transplantation 1987; 44: 412.
11. Joyce S, Flye MW, Mohanakumar T. Characterization of kidney cell-specific, non-major histocompatibility complex alloantigen using antibodies eluted from rejected human renal allografts. Transplantation 1988; 46: 362.
12. Yard B, Spruyt-Gerritse M, Claas F, et al. The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation. Transplantation 1993; 55: 1287.
13. Cerilli J, Bay W, Brasile L. The significance of the monocyte crossmatch in recipients of related HLA identical kidney graft. Hum Immunol 1983; 7: 45.
14. Jordan SC, Yap HK, Sakai RS, et al. Hyperacute cardiac allograft rejection mediated by antiendothelial cell antibodies with a negative monocyte crossmatch. Transplantation 1988; 46: 585.
15. Billingham M, Cary N, Hammond E, Kemnitz J, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990; 9: 587.
16. Jaffe EA, Nachman RL, Becker C, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745.
17. Rappaport VJ, Hirata G, Yap HK, Jordan SC. Anti-vascular endothelial cell antibodies in severe preeclampsia. Am J Obstet Gynecol 1990; 162: 138.
18. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735.
19. Auchincloss H. Xenografting: a review. Transplant Rev 1990; 4: 14.
20. Kooijmans-Coutinho MF, Hermans J, Schrama E, et al. Interstitial rejection, vascular rejection, and diffuse thrombosis of renal allografts: predisposing factors, histology, immunohistochemistry, and relation to outcome. Transplantation 1996; 61: 1338.
21. Cherry R, Nielsen H, Reed E, Reemtsma K, Suciu-Foca N, Marboe C. Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J Heart Lung Transplant 1992; 11: 24.
22. Hammond E, Wittwer C, Greenwood J, Knape W, et al. Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis. Transplantation 1990; 50: 776.
23. Jordan SC, Barkley SC, Lemire JM, Sakai RS, Cohen A, Fine RN. Spontaneous anti-tubular-basement-membrane antibody production by lymphocytes isolated from a rejected allograft. Transplantation 1986; 41: 173.
24. Labarrere CA, Pitts D, Halbrook H, Faulk WP. Immunoglobulin M antibodies in transplanted human hearts. J Heart Lung Transplant 1993; 12: 394.
25. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992; 339: 1566.
26. Hosenpud JD, Everett JP, Morris TE, Mauck KA, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995; 92: 205.
27. Hosenpud JD. Immune mechanisms of cardiac allograft vasculopathy: an update. Transpl Immunol 1993; 1: 237.
28. Leung DTM, Collins T, Lapierre LA, Geha RS, Pober JS. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986; 77: 1428.
29. Van Der Zee JM, Siegert EH, De Vreede TA, et al. Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE). Clin Exp Immunol 1991; 84: 238.
30. Heurkens AHM, Hiemstra PS, Lafeber GJM, Daha MR, Breedveld FC. Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol 1989; 78: 7.
31. Leung DYM, Havens PL, Moake JL, Kim M, Pober JS. Lytic anti-endothelial cell bodies in haemolytic-ureamic syndrome. Lancet 1988; 2: 183.
32. Yap HK, Sakai RS, Bahn L, et al. Anti-vascular endothelial cell antibodies in patients with IgA nephropathy: frequency and clinical significance. Clin Immunol Immunopathol 1988; 49: 450.
33. Page C, Rose M, Yacoub M, Pigott R. Antigenic heterogeneity of vascular endothelium. Am J Pathol 1992; 141: 673.
34. Pober JS, Gimbrone MA, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, et al. Ia expression by vascular endothelium is inducible by activated T cells and by human γ-interferon. J Exp Med 1983; 157: 1339.
35. Dunn MJ, Rose ML, Latif N, et al. Demonstration of Western blotting of antiheart antibodies before and after cardiac transplantation. Transplantation 1991; 51: 806.
36. Wheeler CH, Collins A, Dunn MJ, Crisp SJ, Yacoub MH, Rose ML. Characterization of endothelial antigens associated with transplant-associated coronary artery disease. J Heart Lung Transplant 1995; 14: S188.